Real-time enrollment status for this late-onset pompe disease clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 8:12 AM UTC
| NCT Number | NCT07354724 |
| Recruiting Status | Recruiting |
| Condition | Late-onset Pompe Disease |
| Phase | PHASE1 |
| Target Enrollment | 32 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Denali Therapeutics Inc. |
| Last Updated on CT.gov | August 17, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT07354724 is currently recruiting participants. This phase1 study for late-onset pompe disease is actively seeking new participants at 4 locations across the United States. The study is sponsored by Denali Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07354724 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07354724 was last updated 2 weeks ago (August 17, 2026). HelloStudys verifies this status automatically.